Anti-Neprilysin Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibodies raised against the cytoplasmic domain of human neprilysin (MME, CD10), validated for Western blot.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential
UniProt
P08473
Size
100ug
Cat. #
RP4Neprilysin

In stock

SKU
RP-Neprilysin

Options

As low as: $130.00

Target Overview

Neprilysin (EC 3.4.24.11, gene symbol MME, UniProt P08473) is a type II transmembrane zinc metallopeptidase with thermolysin-like substrate specificity, primarily acting on polypeptides up to 30 amino acids in length. Also known as neutral endopeptidase 24.11 (NEP) or CD10, neprilysin is anchored to the cell membrane and catalyzes the hydrolysis of biologically active peptides including enkephalins, bradykinin, substance P, neurotensin, and the natriuretic peptides ANF and BNP. The enzyme cleaves peptide bonds on the amino side of hydrophobic residues, contributing to neuropeptide metabolism, blood pressure regulation, and inflammatory signaling. Neprilysin is expressed in kidney epithelium, vascular endothelium, fibroblasts, and central nervous system neurons, and is used clinically as a surface marker for common acute lymphocytic leukemia (CALLA). Researchers study neprilysin in contexts ranging from Alzheimer disease—where it degrades amyloid-beta peptides—to cardiovascular physiology, pain modulation, and hematologic malignancies. The cytoplasmic domain targeted by these antibodies provides reliable detection across denaturing and native applications.

Background

Neprilysin has attracted sustained research interest due to its role in peptide hormone inactivation and neurodegenerative disease. The enzyme degrades enkephalins by cleaving the Gly-Phe bond, modulating opioid signaling and nociception. It also processes angiotensin peptides and natriuretic factors, making it a therapeutic target in heart failure; sacubitril/valsartan, a neprilysin inhibitor combined with an angiotensin receptor blocker, is now standard therapy for reduced ejection fraction heart failure. In the central nervous system, neprilysin contributes to amyloid-beta clearance, and reduced neprilysin activity has been implicated in Alzheimer pathogenesis. Recent proteomic studies have identified neprilysin as a differentially regulated protein in depression and rheumatoid arthritis, suggesting broader roles in neuro-immune-metabolic crosstalk. Hui J et al (2026) reported dynamical proteomic signatures for depression across preclinical stages in a prospective cohort of over 52,000 individuals, highlighting neprilysin among proteins with altered abundance trajectories. In oncology, neprilysin (CD10) serves as a lineage marker in acute lymphoblastic leukemia and is expressed in certain solid tumors. The enzyme also exhibits UV-inducible elastase activity toward dermal elastic fibers, implicating it in photoaging and fibrotic skin disorders. Four rabbit polyclonal antibodies raised against the cytoplasmic domain of human neprilysin are available from Triple Point Biologics, each validated for Western blot applications in human samples.

References

  1. Hui J et al (2026) Dynamical proteomic signatures for depression across preclinical stages in 52,121 individuals from a prospective cohort study. World J Biol Psychiatry. PubMed · DOI
  2. Wang Q et al (2026) Multisite Chronic Pain Reveals Neuro-Immune-Metabolic Dysregulation across Rheumatoid Arthritis and Depression. Research (Wash D C). PubMed · DOI
  3. S T et al (2026) The neuroprotective potential of diosgenin: an integrated in silico, in vitro, and in vivo approach in colchicine-induced Alzheimer's model. J Comput Aided Mol Des. PubMed · DOI

Additional Specifications

Gene Symbol MME
UniProt ID P08473
Host Species Rabbit
Species Reactivity Validated- Human
Potential
Pack Size 100ug
Immunogen (Cytoplasmic domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 1-26.
Immunogen (Stalk region)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 9-28.
Immunogen (Propeptide domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 1-55.
Immunogen (Catalytic domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 56-750.
Alternate Names MME, Neutral endopeptidase 24.11, NEP, CD10, Common acute lymphocytic leukemia antigen, CALLA, Enkephalinase, Atriopeptidase, Skin fibroblast elastase, Neutral endopeptidase, EC 3.4.24.11

Frequently Asked Questions

What molecular weight band should I expect for Neprilysin on Western blot?

Neprilysin migrates as a single band at approximately 90-100 kDa on reducing SDS-PAGE, reflecting the full-length glycosylated protein. The predicted molecular weight from the amino acid sequence is around 86 kDa, but N-glycosylation at multiple sites increases the apparent mass. If you see multiple bands, consider that proteolytic cleavage can generate smaller fragments, particularly in samples with active proteases. Including protease inhibitors during lysis is critical. The type II membrane topology means the bulk of the protein is extracellular, so expect robust signal in membrane fractions and lower abundance in cytosolic preparations.

What starting dilution should I use for this Neprilysin antibody in Western blot?

We recommend starting at 1:1000 dilution for Western blot based on validation data with human samples. This dilution typically provides clean signal with low background when using standard chemiluminescent detection. If your lysate has low Neprilysin expression or you are working with tissues other than kidney or brain, you may need to increase concentration to 1:500. Conversely, kidney cortex and certain tumor lines express high levels and may permit dilution to 1:2000. Always include a titration series with your first sample type to establish optimal signal-to-noise for your specific application and detection system.

Is this Neprilysin antibody likely to work in mouse or rat samples?

This antibody is validated for human Neprilysin. Mouse and rat Neprilysin share approximately 85-88 percent sequence identity with human, so cross-reactivity is possible but not guaranteed. If you plan to use mouse or rat samples, we recommend testing a dilution series starting at 1:500 with a positive control tissue such as kidney cortex, which expresses high endogenous Neprilysin across species. Include a known mouse or rat Neprilysin-positive lysate if available. Cross-reactivity should be confirmed empirically in your hands; we cannot provide validated dilutions for species beyond those explicitly tested.

What are good positive and negative control tissues for Neprilysin expression?

Kidney cortex is the gold-standard positive control, showing robust Neprilysin expression in proximal tubule brush border membranes. Brain tissue, particularly striatum and cortex, also expresses significant levels in neuronal membranes. For cell lines, certain leukemias and lymphomas express CD10/Neprilysin strongly. Negative controls include most hematopoietic cells outside the lymphoid lineage and hepatocytes, which have minimal to undetectable expression. When troubleshooting, compare signal intensity between kidney and a low-expression tissue on the same blot. This internal comparison confirms antibody specificity and helps optimize dilution for less abundant samples.

Does Neprilysin have splice isoforms I need to consider when interpreting Western blots?

Neprilysin is predominantly expressed as a single full-length isoform encoded by the MME gene. Alternative splicing has been reported in the literature but is rare and not well-characterized functionally. You should expect one major band around 90-100 kDa in most samples. Soluble forms of Neprilysin generated by ectodomain shedding have been described and may appear as slightly smaller bands if present in serum or conditioned media. If you observe multiple bands in cell lysates, suspect post-translational modifications such as differential glycosylation or proteolytic processing rather than splice variants. Review your sample preparation to ensure protease inhibitors are included.

Can I use this antibody for immunohistochemistry or immunofluorescence on Neprilysin?

Triple Point Biologics antibodies are validated for Western blot and immunohistochemistry as standard applications. This rabbit polyclonal should be suitable for IHC and immunofluorescence on fixed tissue sections or cultured cells, though optimal conditions must be determined empirically. For IHC, start with a 1:100 to 1:200 dilution and antigen retrieval in citrate buffer. Neprilysin localizes to the plasma membrane, so expect rim staining in positive cells. Kidney sections provide excellent positive controls with strong staining in proximal tubule brush borders. Always include secondary-only controls to assess non-specific binding, particularly in tissues with high endogenous immunoglobulin.

How should I prepare cell lysates to preserve Neprilysin for Western blot detection?

Neprilysin is a membrane-bound metallopeptidase, so use lysis buffers containing non-ionic detergents such as 1 percent Triton X-100 or NP-40 to solubilize membranes efficiently. Include protease inhibitors immediately upon lysis; Neprilysin itself is a protease and sample degradation is common without inhibition. EDTA-containing inhibitor cocktails are acceptable and will not interfere with antibody recognition. Avoid repeated freeze-thaw cycles, which can promote aggregation of membrane proteins. For subcellular fractionation studies, Neprilysin partitions primarily with membrane fractions. Load 20-40 micrograms total protein per lane as a starting point for detection in moderate-expression samples.

What is the recommended storage condition and shelf life for this Neprilysin antibody?

Store the antibody at -20 degrees Celsius in single-use aliquots to avoid repeated freeze-thaw cycles, which can reduce titer and increase aggregation. The antibody is supplied at 100 micrograms per vial in a stabilization buffer. Once thawed, aliquots remain stable for at least six months at -20 degrees Celsius and can be kept at 4 degrees Celsius for up to one month for frequent use. Do not store diluted antibody; prepare working dilutions fresh in blocking buffer on the day of use. If you observe increased background or loss of signal over time, prepare a fresh aliquot. Avoid contamination by using sterile technique when removing aliquots from stock vials.

Western blot validation for RP-Neprilysin — 4 panels across the domain-specific antibody variants. Each blot below shows the clone that validates a specific domain of the target protein.

Neprilysin: Cytoplasmic domain — WB validation
WB · Panel 1 Neprilysin: Cytoplasmic domain
Neprilysin: Stalk region — WB validation
WB · Panel 2 Neprilysin: Stalk region
Neprilysin: Propeptide domain — WB validation
WB · Panel 3 Neprilysin: Propeptide domain
Neprilysin: Catalytic domain — WB validation
WB · Panel 4 Neprilysin: Catalytic domain

Custom validation studies available on request — contact us.

Also known as:

  • MME
  • Neutral endopeptidase 24.11
  • NEP
  • CD10
  • Common acute lymphocytic leukemia antigen
  • CALLA
  • Enkephalinase
  • Atriopeptidase
  • Skin fibroblast elastase
  • Neutral endopeptidase
  • EC 3.4.24.11
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →